Article History
Received: 21 April 2023
Accepted: 14 June 2023
First Online: 23 June 2023
Declarations
:
: This is an observational study. The study was approved from Institutional Review Board at Mayo Clinic and has confirmed that no ethical approval is required.
: SK receives research support from Rebioitx/Ferring, Vedanta, Finch, Seres, and Pfizer. SK serves as a consultant for ProbioTech, Takeda, Niche, and Immuron. DSP has grant funding from Pfizer, Vedanta, Seres, Finch, Applied Molecular Transport, and Takeda. He has consulted for Vedanta, Seres, AbbVie, Immunic, and Otsuka.